KR100451885B1 - Extracts of pomegranate for stoping the hair from falling out and composition of cosmetics containing the extracts of pomegranate - Google Patents
Extracts of pomegranate for stoping the hair from falling out and composition of cosmetics containing the extracts of pomegranate Download PDFInfo
- Publication number
- KR100451885B1 KR100451885B1 KR10-2002-0008131A KR20020008131A KR100451885B1 KR 100451885 B1 KR100451885 B1 KR 100451885B1 KR 20020008131 A KR20020008131 A KR 20020008131A KR 100451885 B1 KR100451885 B1 KR 100451885B1
- Authority
- KR
- South Korea
- Prior art keywords
- hair
- hair loss
- pomegranate
- pomegranate extract
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 26
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 235000014360 Punica granatum Nutrition 0.000 title description 20
- 241000219991 Lythraceae Species 0.000 title description 19
- 239000000284 extract Substances 0.000 title description 6
- 229940109529 pomegranate extract Drugs 0.000 claims abstract description 34
- 230000003658 preventing hair loss Effects 0.000 claims abstract description 24
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 claims abstract description 16
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 18
- 239000006210 lotion Substances 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- -1 hair rinse Substances 0.000 claims description 5
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 3
- 239000000443 aerosol Substances 0.000 claims description 3
- 239000000975 dye Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000004359 castor oil Substances 0.000 claims description 2
- 235000019438 castor oil Nutrition 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
- 239000008266 hair spray Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000002453 shampoo Substances 0.000 claims description 2
- 230000001256 tonic effect Effects 0.000 claims description 2
- 230000003656 anti-hair-loss Effects 0.000 claims 1
- 239000002304 perfume Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 27
- 201000004384 Alopecia Diseases 0.000 abstract description 19
- 230000003676 hair loss Effects 0.000 abstract description 15
- 208000024963 hair loss Diseases 0.000 abstract description 15
- 208000024891 symptom Diseases 0.000 abstract description 6
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 12
- 229940088597 hormone Drugs 0.000 description 12
- 239000005556 hormone Substances 0.000 description 12
- 230000003779 hair growth Effects 0.000 description 7
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 6
- 229940011871 estrogen Drugs 0.000 description 6
- 239000000262 estrogen Substances 0.000 description 6
- 229960003604 testosterone Drugs 0.000 description 6
- 229960003473 androstanolone Drugs 0.000 description 5
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 5
- 150000002515 isoflavone derivatives Chemical class 0.000 description 5
- 235000008696 isoflavones Nutrition 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- JEIZLWNUBXHADF-UHFFFAOYSA-N Pelletierine Chemical compound CC(=O)CC1CCCCN1 JEIZLWNUBXHADF-UHFFFAOYSA-N 0.000 description 2
- 244000294611 Punica granatum Species 0.000 description 2
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000003990 capacitor Substances 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 208000008742 seborrheic dermatitis Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- YVIMHTIMVIIXBQ-UHFFFAOYSA-N [SnH3][Al] Chemical compound [SnH3][Al] YVIMHTIMVIIXBQ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- RSIHSRDYCUFFLA-DYKIIFRCSA-N boldenone Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 RSIHSRDYCUFFLA-DYKIIFRCSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- RSIHSRDYCUFFLA-UHFFFAOYSA-N dehydrotestosterone Natural products O=C1C=CC2(C)C3CCC(C)(C(CC4)O)C4C3CCC2=C1 RSIHSRDYCUFFLA-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000002223 garnet Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 5알파-리덕타아제 억제활성을 갖는 탈모방지용 석류추출물 및 이를 포함하여 이루어짐을 특징으로 하는 탈모방지용 화장료 조성물에 관한 것으로, 본 발명에 의하면 석류 추출물이 탈모 증상의 주원인인 5알파-리덕타아제의 활성을 억제하여 인체에서 어떠한 부작용도 일으키지 않으면서도 우수한 탈모방지 효과를 발휘한다.The present invention relates to a hair loss preventing pomegranate extract having a 5-alpha-reductase inhibitory activity and a cosmetic composition for preventing hair loss, comprising the same. According to the present invention, 5 alpha -ri which is the main cause of hair loss symptoms By suppressing the activity of ductase, it shows excellent hair loss prevention effect without causing any side effects in the human body.
[색인어] 탈모방지, 석류추출물, 화장료[Index] Hair Loss Prevention, Pomegranate Extract, Cosmetics
Description
본 발명은 탈모방지용 석류추출물 및 이를 포함하는 탈모방지용 화장료 조성물에 관한 것으로, 더욱 상세하게는 석류과실 및 석류종자의 추출물을 사용함으로서 탈모방지의 효과가 우수한 탈모방지용 화장료 조성물에 관한 것이다.The present invention relates to a hair loss prevention pomegranate extract and a cosmetic composition for preventing hair loss, and more particularly, to a hair loss prevention cosmetic composition having an excellent effect of preventing hair loss by using an extract of pomegranate fruit and pomegranate seeds.
현대 사회에 들어 각종 스트레스와 환경오염, 약물 중독 및 오남용 등으로 인한 부작용, 파마, 염색, 정발제류의 사용과 유전적인 요인 등으로 인한 탈모의 발생이 더욱 심각해짐에 따라 발모 또는 육모 대한 관심이 증가되고 있지만, 발모, 육모에 관한 의학적 지식 및 생리적 작용에 관해서는 아직 큰 진전을 보이고 있지 않은 실정이다.In modern society, as the occurrence of hair loss due to various effects such as stress, environmental pollution, drug addiction and misuse, perm, dyeing, use of hair dressings and genetic factors increases, interest in hair growth or hair growth increases. However, the medical knowledge and physiological effects of hair growth, hair growth have not yet made great progress.
남성형 탈모증상은 크게 두 가지로 구분되는데, 남성호르몬 의존성 만성형 탈모와 지루성 피부염에 의한 탈모가 있다. 전자는 남성 호르몬의 양에 직접 관련되며, 후자는 피지관련 질환으로 남성호르몬의 하나인 테스토스테론(Testosterone)이 5알파-리덕타아제(5α-reductase)에 의해 또 다른 남성호르몬의 하나인 디하이드로테스토스테론(dihydrotestosterone:DHT)으로 전환되고 이 호르몬의 비정상적인 과잉으로 인한 과잉 피지 생성으로 인하여 발병한다.There are two types of androgenetic alopecia, which are male hormone-dependent chronic type alopecia and hair loss caused by seborrheic dermatitis. The former is directly related to the amount of androgen hormones, and the latter is sebum-related disease. Testosterone, one of the male hormones, is dehydrotestosterone, one of the other male hormones, by 5 alpha-reductase. It is converted to dihydrotestosterone (DHT) and develops due to excess sebum production due to abnormal excess of this hormone.
종래에는 이러한 지루성 피부염의 치료를 위해 항균제를 사용하거나, 알파하이드록시산(AHA: alpha hydroxy acid), 비타민 A와 같은 각질제거제를 사용하였으나, 효과가 미미하거나 과량 사용시 피부자극이 심하여 극히 제한된 양만이 사용되고 있다. 일반적으로 사용되는 항균제로는 레트라사이클린 등의 항생물질이 있으며, 이러한 항생물질은 내균성의 출혈 또는 광과민작용 등의 부작용을 일으킬 가능성이 큰 것으로 알려져 있다.Conventionally, antibacterial agents or exfoliants such as alpha hydroxy acid (AHA) and vitamin A have been used for the treatment of seborrheic dermatitis, but only a very limited amount is used due to the slight irritation or excessive skin irritation. It is used. Antimicrobials that are commonly used include antibiotics such as retracycline, and these antibiotics are known to have a high possibility of causing side effects such as bactericidal bleeding or photosensitivity.
또한, 테스토스테론을 디하이드로테스토스테론으로 전환시키므로서 탈모의 원인이 되고 있는 5알파-리덕타아제의 활성을 억제하려는 연구가 보고되어 있으나(Yasuro sugimoto et al., cation inhibit specifically type Ⅰ 5α-reductase found in human skin, J. Invest. Dermatol., 104, 1995), 그 효과나 실효성이 적고, 상당한 주의가 필요한 것으로 알려져 있다.In addition, studies have been reported to inhibit the activity of 5-alpha-reductase, which causes hair loss by converting testosterone to dihydrotestosterone (Yasuro sugimoto et al., Cation inhibit specifically type I 5α-reductase found in human skin, J. Invest.Dermatol., 104, 1995), its effect and effectiveness are known to be small and considerable care is required.
또한 발모를 촉진하기 위한 약물들이 이미 공개되어 있는데, 미합중국특허 제4,596,812호는 업존사(Upjohn Co. Ltd)의 미녹시딜(Minoxidile)을 개시하고 있고, 일본공개특허 제41/1985호는 홀수의 탄소수를 가지는 알코올과 그 유도체를 개시하고 있으며, 일본공개특허 제20732/1986호는 탄소수 22 내지 34의 고급지방산 알코올류를 개시하고 있다. 또한 대한민국특허공보 제96-14776호는 발모 촉진용 화장품 조성물로서 글리실-L히스티딜-L-리신:구리(Ⅱ)(GHL-Cu)유도체의 용도 및 온혈동물의 발모촉진에 대해 기재하고 있다. 그러나 이러한 제제들은 호르몬류 등으로 부작용이 생기기 쉽고, 활성성분이 합성화합물로서 인체 내에서 불안정하며, 충분한 효과를 가지고 있지 않다.In addition, drugs to promote hair growth have already been disclosed, US Pat. No. 4,596,812 discloses Minoxidil of Upjohn Co. Ltd, and Japanese Patent No. 41/1985 discloses an odd carbon number. Eggplant discloses an alcohol and a derivative thereof, and Japanese Patent Laid-Open No. 20732/1986 discloses higher fatty acid alcohols having 22 to 34 carbon atoms. In addition, Korean Patent Publication No. 96-14776 describes the use of glycyl-L histidyl-L-lysine: copper (II) (GHL-Cu) derivatives as a cosmetic composition for promoting hair growth and hair growth promoting of warm-blooded animals. . However, these agents are prone to side effects such as hormones, the active ingredient is a synthetic compound, unstable in the human body, does not have a sufficient effect.
본 발명자는 탈모증상을 방지 또는 치료하기 위한 연구 과정 중 5알파-리덕타아제가 남성호르몬인 테스토스테론을 디하이드로테스토스테론으로 전환시키고 이 호르몬의 과잉이 탈모 증상을 발병시킨다는 사실과 이러한 5알파-리덕타아제의 활성을 억제하는데 있어서 석류 추출물이 효과적임을 확인하고, 본 발명을 완성하게 된 것이다.In the course of research to prevent or treat alopecia, the inventors found that 5 alpha-reductase converts testosterone, a male hormone, to dihydrotestosterone, and that the excess of this hormone causes hair loss symptoms. Confirming that pomegranate extract is effective in inhibiting the activity of the present invention will be completed.
따라서, 본 발명은 상기와 같이 인체에서의 부작용 등의 문제점 없이 탈모 효과가 우수한 석류추출물 및 이를 포함하는 탈모방지용 화장료 조성물을 제공하는 것을 목적으로 한다.Therefore, an object of the present invention is to provide a pomegranate extract excellent in hair loss effect and hair loss prevention cosmetic composition comprising the same without problems such as side effects in the human body as described above.
상기의 목적을 달성하기 위한 본 발명은 물, 에탄올, 프로필렌글리콜, 부틸렌글리콜 또는 이들 중 2 이상의 혼합물을 포함하여 이루어지는 그룹에서 선택되는 어느 하나의 용제로 추출하며, 5알파-리덕타아제 억제활성을 갖는 탈모방지용 석류추출물을 제공한다.The present invention for achieving the above object is extracted with any one solvent selected from the group consisting of water, ethanol, propylene glycol, butylene glycol or a mixture of two or more thereof, 5 alpha-reductase inhibitory activity It provides a pomegranate extract for preventing hair loss.
또한, 본 발명은 상기 탈모방지용 석류추출물을 포함하여 이루어짐을 특징으로 하는 탈모방지용 화장료 조성물을 제공한다.In addition, the present invention provides a cosmetic composition for preventing hair loss, comprising the pomegranate extract for preventing hair loss.
또한, 본 발명은 상기 탈모방지용 화장료 조성물을 이용한 화장품을 제공한다.In addition, the present invention provides a cosmetic using the cosmetic composition for preventing hair loss.
이하, 본 발명을 보다 상세하게 설명하기로 한다.Hereinafter, the present invention will be described in more detail.
본 발명에서 탈모방지용 석류추출물은 석류(Punicagranatum L.)로부터 추출하여 얻는데, 상기 석류는 석류나무과(Punicaceae)의 낙엽지는 넓은 잎 큰 키 나무인 석류나무의 열매를 말하는 것으로, 안석류, 산석류, 감석류 등으로도 부른다. 원산지는 소아시아로 알려져 있으며, 현재는 중국, 미국 캘리포니아, 인도 등지에서 대량으로 재배되고 있고 우리나라에서는 식용, 관상용, 약용으로 심고 있는데, 남부지방에서는 월동이 가능하여 정원수로 많이 심고 있다. 초여름에는 짙은 주홍색의 꽃이 피고 가을에는 석류가 둥글게 익는다. 나무껍질과 뿌리에는 펠레티에린(Pelletierine)이 함유되어 있어서 구충제로 쓰이고, 인도네시아에서는 부인병이나 적리의 치료에 열매를 사용한다. 열매의 껍질은 탄닌과 알칼로이드를 많이 함유하고 있어서 지사제 등으로 약용하기도 하고 염색에도 이용된다. 줄기, 나무껍질, 잎 등도 염색에 사용할 수 있는데, 알칼리 매염으로 황갈색, 알루미늄이나 주석 매염에 의하여 황색으로 염색할 수 있다.Pomegranate extract for preventing hair loss in the present invention is obtained by extracting from the pomegranate (Punicagranatum L.), the pomegranate is a deciduous branch of the pomegranate (Punicaceae) refers to the fruit of the pomegranate tree, which is a broad-leaved large tree, eye stones, garnet, Also called pomegranate. Origin is known as Asia Minor, and is currently grown in large quantities in China, the United States, California, India, etc. It is planted in Korea as edible, ornamental, and medicinal. In early summer, dark vermilion flowers bloom, and in the fall, pomegranates round ripe. The bark and roots contain Pelletierine, which is used as an insect repellent. In Indonesia, the fruit is used for the treatment of gynecological diseases and redness. The bark of the fruit contains a lot of tannins and alkaloids. Stems, bark, leaves, etc. can also be used for dyeing, which can be dyed yellow by alkali tan, yellow, or aluminum tin.
석류의 함유 성분으로는 포도당 21.8%, 과당 24.56% 등이 있는데, 다른 식물군에 비해 100g당 당의 함량이 두드러지게 높다. 또한, 칼슘, 칼륨, 마그네슘, 아연, 철분 등 우리 몸에서 중요한 기능을 수행하는 미네랄 성분들을 풍부하게 가지고 있는데, 상기 마그네슘, 아연, 철분 3가지의 미네랄 성분을 동시에 포함하는 것은 석류뿐이다. 그 외에 석류는 비타민 B1, 비타민 B2, 비타민 C 등의 비타민을 함유하고 있어서 신체내에서 각종 기능의 조절 및 질병들을 예방하기 위한 좋은 영양소를 제공한다.Pomegranate contains 21.8% glucose and 24.56% fructose, which is significantly higher in sugar content than 100g. In addition, calcium, potassium, magnesium, zinc, iron and abundant minerals that perform important functions in our body, such as magnesium, zinc, iron and pomegranate containing only three mineral components at the same time. In addition, pomegranate contains vitamins such as vitamin B1, vitamin B2, and vitamin C, which provide good nutrients for controlling various functions and preventing diseases in the body.
또한, 석류종자에는 1kg당 17mg의 식물성 에스트로겐인 이소플라본이 함유되어 있다. 여성의 피부는 여성호르몬인 에스트로겐(Estrogen)의 작용으로인해 남성과 달리 탄력, 보습의 유지 및 피부 세포조직이 강화되고 피지분비가 적으며 털이 적은 특징을 가진다. 그러나, 에스트로겐의 분비 장소인 생식기관이 나이가 들어감에 따라 점차 기능이 퇴화되면서 여성호르몬 결핍에 따른 피부 노화 및 건조 현상이 두드러지고 피부가 얇아지며 탄력이 감소하게 된다. 석류종자에는 상기와 같은 에스트로겐과 유사한 화학구조를 갖고 있으면서 에스트로겐과 유사한 기능을 할 뿐만 아니라, 특히 대두나 칡으로부터 추출하여 많은 항암제로서의 역할을 수행하는 식물성 호르몬인 이소플라본을 함유하고 있다.Pomegranate seeds also contain isoflavones, 17 mg of vegetable estrogen per kilogram. Female skin is characterized by the action of female hormone estrogen (Estrogen), unlike males, it has the characteristics of elasticity, moisturization and skin tissues, less sebum secretion, less hair. However, as the reproductive organs, the site of estrogen secretion, age gradually deteriorate, aging and dryness of skin due to female hormone deficiency become more pronounced, skin becomes thinner, and elasticity decreases. Pomegranate seeds have a chemical structure similar to that of estrogens above and contain isoflavones, which are plant hormones that function not only as estrogens but also as extracts from soybeans and mussels, and act as anticancer agents.
이러한 이소플라본과 관련하여서 대한민국특허 제1204411호는 이소플라본의 멜라닌 생성 억제효과에 관하여 기술하며, 미국특허 제5,679,806호는 대두와 칡으로부터 에탄올이나 메탄올을 이용하여 추출, 정제하는 일련의 공정을 거쳐 이소플라본만을 추출하는 방법에 관하여 기술하며, 미국특허 제4,524,067호는 대두로부터 가성소오다를 사용하여 추출한 후 일련의 공정을 거쳐 단백질, 올리고당, 사포닌, 이소플라본 등을 분리하는 방법을 기술하고 있다.In relation to such isoflavones, Korean Patent No. 1204411 describes the effect of inhibiting melanin production of isoflavones, and US Patent No. 5,679,806 undergoes a series of processes of extracting and purifying soybeans and ethanol using ethanol or methanol. A method of extracting only flavones is described, and US Pat. No. 4,524,067 describes a method for separating proteins, oligosaccharides, saponins, isoflavones, etc. after extracting using caustic soda from soybean.
이와 같이 우수한 효능을 발휘하여 많은 부분에 기여하고 있으면서도 우리 몸에 적용하는데 있어서도 유해하지 않은 석류를 추출하여 본 발명에서는 탈모를 예방하고 치료하기 위해 사용한다.In this way, by extracting pomegranate, which is not harmful to apply to our body while also contributing to many parts by exhibiting excellent efficacy, it is used to prevent and treat hair loss in the present invention.
본 발명에서 석류추출물은 남성호르몬인 테스토스테론을 디하이드로테스토스테론으로 전환시키고 이 호르몬의 과잉으로 탈모를 유발시키는 5알파-리덕타아제의활성을 억제하는 작용을 한다.Pomegranate extract in the present invention converts testosterone, a male hormone, to dihydrotestosterone and acts to inhibit the activity of 5-alpha-reductase, which causes hair loss due to excess of this hormone.
석류추출물을 획득하기 위한 방법의 한 일예는 하기와 같다.One example of a method for obtaining a pomegranate extract is as follows.
석류를 중량변화가 없을 때까지 건조시킨 후 분쇄하여 얻은 분쇄물 을 용제에 넣고 냉각콘덴서가 달린 환류 추출기로 60 내지 100℃, 2 내지 4시간 동안 가열하여 추출한 다음 여과포로 여과한 후 잔사를 같은 방법으로 1회 이상 더 추출할 수 있다. 상기 용제로는 부틸렌 글리콜, 프로필렌 글리콜, 에탄올, 물 등을 사용할 수 있으며, 또한 상기 환류 추출기의 온도 조건을 60 내지 100℃로 하는 것이 바람직한데, 이는 60℃ 미만에서는 추출이 잘 이루어지지 않으며 100℃를 초과하는 경우에는 다른 불순물이 함께 추출되기 때문이다. 이렇게 하여 얻은 추출물을 합하여 냉각콘덴서가 달린 증류장치로 감압 농축한 후 동결 또는 분무 건조하여 건조된 석류추출물을 얻는다.After drying the pomegranate until there is no change in weight, the pulverized product obtained by pulverization is put in a solvent, heated to a reflux extractor equipped with a cooling condenser for 60 to 100 ° C. for 2 to 4 hours, and then filtered through a filter cloth. Can be extracted more than once. Butylene glycol, propylene glycol, ethanol, water, etc. may be used as the solvent, and it is preferable to set the temperature condition of the reflux extractor to 60 to 100 ° C, which is difficult to extract below 60 ° C. This is because other impurities are extracted together when the temperature is exceeded. The extract thus obtained is combined and concentrated under reduced pressure with a distillation apparatus equipped with a cooling capacitor, followed by freezing or spray drying to obtain a dried pomegranate extract.
상기와 같이 얻은 석류추출물을 화장료에 함유시켜 탈모방지의 효과를 발휘하게 하기 위해서 화장료에 포함되어야할 석류추출물의 함량은 건조중량으로 0.0001 내지 10.0중량%가 바람직한데, 이는 0.0001중량% 미만에서는 뚜렷한 효과를 기대할 수 없고 10.0중량%를 초과하면 함유량의 증가에 따른 뚜렷한 효과의 증가가 나타나지 않기 때문이다. 더욱 바람직하게는 0.001 내지 5.0 중량%가 좋다.In order to contain the pomegranate extract obtained as described above in order to exhibit the effect of preventing hair loss, the content of the pomegranate extract to be included in the cosmetic is preferably 0.0001 to 10.0% by weight in dry weight, which is a distinct effect at less than 0.0001% by weight. This is because when it is not expected to exceed 10.0% by weight, there is no apparent increase in effect with the increase of the content. More preferably 0.001 to 5.0% by weight.
또한, 본 발명은 석류추출물을 함유한 탈모방지용 화장료 조성물을 포함하는 화장품을 제공하는데, 통상의 모발용 화장료 성분들에 석류추출물을 배합하여 제조할 수 있다. 상기 통상의 모발용 화장료 성분들로는 에탄올, 경화된 캐스터 오일(에틸렌 옥시드 함유), 향료 및 염료 등 당업자에게는 상용적으로 구입하여 사용할수 있을 정도로 공지된 것이 될 수 있다. 또한, 탈모방지용 화장품의 형태로는 헤어토닉, 헤어크림, 헤어로션, 헤어샴푸, 헤어린스, 헤어스프레이, 헤어에어졸, 포마드, 분말, 젤 등과 같이 용액, 솔젤, 에멀젼, 오일, 왁스, 에어졸 등 다양한 형태로 제조될 수 있으며, 본 발명은 특히 이들에 제한되지는 않는다.In addition, the present invention provides a cosmetic comprising a cosmetic composition for preventing hair loss containing a pomegranate extract, it can be prepared by blending the pomegranate extract in conventional hair cosmetic ingredients. The conventional hair cosmetic ingredients may be well known to those skilled in the art such as ethanol, cured castor oil (containing ethylene oxide), fragrances and dyes. In addition, hair loss prevention cosmetics in the form of hair tonic, hair cream, hair lotion, hair shampoo, hair rinse, hair spray, hair aerosol, pomade, powder, gel, such as a variety of solutions, sol gel, emulsion, oil, wax, aerosol, etc. It may be prepared in a form, and the present invention is not particularly limited thereto.
이하, 본 발명을 실시예 및 비교예를 통하여 더욱 상세하게 설명하겠는바, 본 발명이 하기 실시예에 의해 제한되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples and Comparative Examples, but the present invention is not limited by the following Examples.
실시예 1 내지 4 와 비교예 1Examples 1 to 4 and Comparative Example 1
[실시예 1]Example 1
석류를 중량변화가 없을 때까지 건조시킨 후, 분쇄하여 얻은 분쇄물 100g을 부틸렌 글리콜 1ℓ에 넣고 냉각콘덴서가 달린 환류 추출기로 80℃, 3시간 동안 가열하여 추출한 다음 300메쉬 여과포로 상온에서 와트만(Whatman) 2번 여과지로 여과하여 불용성 물질을 제거한 후, 냉각콘덴서가 달린 증류장치로 60℃에서 감압 농축한 후 동결 건조하여 건조 중량 22g의 석류추출물을 얻었다.After drying the pomegranate until there is no change in weight, 100 g of the pulverized powder obtained by pulverization was put in 1 l of butylene glycol, and extracted by heating at 80 ° C. for 3 hours using a reflux extractor equipped with a cooling condenser. After filtering by filter paper No. 2, the insoluble substance was removed, and then concentrated under reduced pressure at 60 ° C. using a distillation apparatus equipped with a cooling capacitor, followed by freeze drying to obtain a dry weight of 22 g of pomegranate extract.
석류추출물이 5알파-리덕타아제 활성을 억제시키는 효능을 실험하기 위하여 암컷 쥐 간에서 정제한 5알파-리덕타아제 및 표지 물질인 (3H-1,2,4,5,6,7)테스토스테론을 포함하는 포스페이트 버퍼(PH 6.6)에 상기 실시예에서 얻은 석류추출물의 농도가 0.0005, 0.005, 0.05, 0.5, 5.0%가 되도록하여 첨가하고 37℃에서 15분 동안 반응시켰다. 테스토스테론이 5알파-리덕타아제의 작용에 의해 전환된 디하이드로테스토스테론을 추출하여 HPLC와 방사선 동위원소 측정기를 이용하여 정량하였으며, 본 발명의 비교예로써 석류추출물을 첨가하지 않은 디하이드로테스토스테론피크 면적에 대한 상대적인 값으로써 5알파-리덕타아제의 활성 억제정도를 표 1의 저해율로 나타내었다.Testosterone, a 5alpha-reductase and a labeling substance (3H-1,2,4,5,6,7) purified from female rat livers to examine the efficacy of pomegranate extracts in inhibiting 5-alpha-reductase activity To the phosphate buffer (PH 6.6) containing the concentration of the pomegranate extract obtained in the above example was added to 0.0005, 0.005, 0.05, 0.5, 5.0% and reacted for 15 minutes at 37 ℃. Dihydrotestosterone converted by testosterone by the action of 5 alpha-reductase was extracted and quantified by HPLC and radioisotope measurement. As a relative value, the inhibition rate of 5 alpha-reductase activity is shown as the inhibition rate of Table 1.
[실시예 2 내지 4][Examples 2 to 4]
표 1에서 제시되는 바와 같이 추출용 용제, 추출하여 얻은 석류추출물의 중량, 5알파-리덕타아제의 활성 억제정도를 측정하기 위하여 사용한 석류추출물의 농도를 달리한 것을 제외하고는 실시예 1과 동일하게 하였으며, 그 결과를 표 1에 나타내었다.As shown in Table 1, except that the extraction solvent, the weight of the pomegranate extract obtained by extraction, and the concentration of the pomegranate extract used to measure the degree of activity inhibition of 5 alpha-reductase was the same as in Example 1. The results are shown in Table 1.
실험예 : 실시예 1의 석류 추출물을 함유하는 화장료의 탈모 방지 효과 실험Experimental Example: Experiment to prevent hair loss of cosmetics containing the pomegranate extract of Example 1
50.0중량%의 에탄올(95%), 0.5중량%의 경화된 캐스터 오일(에틸렌 옥시드 40몰 함유), 1.0중량%의 글리세린, 0.005중량%의 석류추출물에 잔량의 물을 가하였고, 추가로 상용적으로 사용되는 향료 또는 염료를 가하여 석류추출물을 함유한 헤어로션을 제조하였고, 이와 비교하기 위하여 상기 성분 중 석류추출물을 함유하지 않은 것을 제외하고는 상기와 동일하게 하여 헤어로션을 제조하였다.Residual water was added to 50.0% by weight of ethanol (95%), 0.5% by weight of cured caster oil (containing 40 moles of ethylene oxide), 1.0% by weight of glycerin, and 0.005% by weight of pomegranate extract. Hair lotion containing pomegranate extract was prepared by adding flavors or dyes, which were used in the same manner, and hair lotion was prepared in the same manner as above except that pomegranate extract did not contain the pomegranate extract.
상기와 같이 제조된 헤어로션의 탈모방지효과를 확인하기 위하여 탈모증이있는 남성 피시험자 20명 중 10명에게는 석류추출물을 함유한 헤어로션을 나머지 10명에게는 석류추출물을 함유하지 않은 헤어로션을 주어 탈모부위에 1일, 2 내지 3회, 2㎖씩 도포하여 효과 확인의 정도에 따라 최소 1개월에서 최대 3개월까지 사용하여 효과 정도를 평가하여 표 2에 나타내었으며, 여기서 평가 기준은 세발시 탈모량, 자각증상, 육안 판정시 효과가 현저한 경우 5점, 중등도인 경우 4점, 경등인 경우 3점, 불변인 경우 2점, 오히려 탈모증상이 악화된 경우 1점으로 하여 평가한 후 평균값으로서 종합적인 판정을 하였다.In order to confirm the hair loss prevention effect of the hair lotion prepared as described above, 10 out of 20 male test subjects with alopecia were given hair lotions containing pomegranate extract, and the remaining 10 were given hair lotions without pomegranate extract. 1 day, 2 to 3 times, 2ml each applied to the site according to the degree of confirming the effect of using at least 1 month up to 3 months to evaluate the degree of effect is shown in Table 2, where the evaluation criteria is hair loss at tribal , 5 symptoms in case of noticeable symptoms and visual effects, 4 points in moderate, 3 points in mild, 2 points in invariant, and 1 point in case of deterioration of hair loss. Judgment was made.
이와 같이 상기 실시예의 결과에서 제시되는 바와 같이 석류 추출물을 함유하는 화장료 조성물은 탈모 증상의 주원인인 5알파-리덕타아제의 활성을 억제하여 인체에서 어떠한 부작용도 일으키지 않으면서도 우수한 탈모방지 효과를 발휘하여 탈모를 예방하고 치료하는 데 있어서 중요한 역할을 하게 된다.As shown in the results of the above embodiment, the cosmetic composition containing the pomegranate extract exhibits an excellent hair loss prevention effect without causing any side effects in the human body by inhibiting the activity of 5 alpha-reductase, which is the main cause of hair loss symptoms. It plays an important role in preventing and treating hair loss.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0008131A KR100451885B1 (en) | 2002-02-15 | 2002-02-15 | Extracts of pomegranate for stoping the hair from falling out and composition of cosmetics containing the extracts of pomegranate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0008131A KR100451885B1 (en) | 2002-02-15 | 2002-02-15 | Extracts of pomegranate for stoping the hair from falling out and composition of cosmetics containing the extracts of pomegranate |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030068647A KR20030068647A (en) | 2003-08-25 |
KR100451885B1 true KR100451885B1 (en) | 2004-10-08 |
Family
ID=32221462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2002-0008131A Expired - Lifetime KR100451885B1 (en) | 2002-02-15 | 2002-02-15 | Extracts of pomegranate for stoping the hair from falling out and composition of cosmetics containing the extracts of pomegranate |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100451885B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101189552B1 (en) * | 2010-01-13 | 2012-10-11 | 오용환 | Hair growing promoter and manufacturing method for the same |
KR102065607B1 (en) | 2019-09-27 | 2020-01-13 | 주식회사 지웨이코스메틱 | cosmetic composition for skin moisturizing and skin elasticity using palm oil fraction |
KR102137252B1 (en) | 2020-04-23 | 2020-07-24 | 주식회사 제이투케이바이오 | fermented extract for preventing stress alopecia using Lactobacillus plantarum J2K-27, and manufacturing method of it, and cosmetic composition containing fermented extract |
KR102369387B1 (en) | 2021-09-10 | 2022-03-08 | (주)한성이비지니스 | Cosmetic Composition for prevention of depilation or improvement of hair growth |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2874502B1 (en) * | 2004-08-26 | 2012-06-08 | Innovat Co Cabinet Ellouze | NOVEL PLANT EXTRACT, PROCESS FOR OBTAINING SAME, AND PHARMACEUTICAL, NUTRACEUTICAL OR COSMETIC APPLICATIONS THEREOF |
KR100862646B1 (en) * | 2006-08-22 | 2008-10-09 | 정학 | Hair dye composition and preparation method thereof |
WO2024258187A1 (en) * | 2023-06-16 | 2024-12-19 | 코스맥스 주식회사 | Composition for strengthening hair roots comprising metal-phenolic complex and melanin or precursor thereof |
KR102738487B1 (en) * | 2023-11-06 | 2024-12-04 | 미 제갈 | Method of manufacturing pomegranate seed extract for preventing hair loss and mist composition for preventing hair loss containing the extract |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000154121A (en) * | 1998-11-19 | 2000-06-06 | Kureha Chem Ind Co Ltd | Hair-restoring and growing composition |
JP2002020242A (en) * | 2000-07-06 | 2002-01-23 | Lion Corp | Hair care preparation composition |
KR20030000708A (en) * | 2001-06-26 | 2003-01-06 | 박현숙 | Preparations to promote hair growth and method for producing thereof |
KR101134813B1 (en) * | 2005-12-16 | 2012-04-13 | 현대자동차주식회사 | a cam for variable valve timing device |
KR101303695B1 (en) * | 2010-10-18 | 2013-09-09 | 대한민국 | 3d scaffolds using low molecules silk firoin and the agarose gel, and production method therof |
-
2002
- 2002-02-15 KR KR10-2002-0008131A patent/KR100451885B1/en not_active Expired - Lifetime
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000154121A (en) * | 1998-11-19 | 2000-06-06 | Kureha Chem Ind Co Ltd | Hair-restoring and growing composition |
JP2002020242A (en) * | 2000-07-06 | 2002-01-23 | Lion Corp | Hair care preparation composition |
KR20030000708A (en) * | 2001-06-26 | 2003-01-06 | 박현숙 | Preparations to promote hair growth and method for producing thereof |
KR101134813B1 (en) * | 2005-12-16 | 2012-04-13 | 현대자동차주식회사 | a cam for variable valve timing device |
KR101303695B1 (en) * | 2010-10-18 | 2013-09-09 | 대한민국 | 3d scaffolds using low molecules silk firoin and the agarose gel, and production method therof |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101189552B1 (en) * | 2010-01-13 | 2012-10-11 | 오용환 | Hair growing promoter and manufacturing method for the same |
KR102065607B1 (en) | 2019-09-27 | 2020-01-13 | 주식회사 지웨이코스메틱 | cosmetic composition for skin moisturizing and skin elasticity using palm oil fraction |
KR102137252B1 (en) | 2020-04-23 | 2020-07-24 | 주식회사 제이투케이바이오 | fermented extract for preventing stress alopecia using Lactobacillus plantarum J2K-27, and manufacturing method of it, and cosmetic composition containing fermented extract |
KR102369387B1 (en) | 2021-09-10 | 2022-03-08 | (주)한성이비지니스 | Cosmetic Composition for prevention of depilation or improvement of hair growth |
Also Published As
Publication number | Publication date |
---|---|
KR20030068647A (en) | 2003-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101393007B1 (en) | Cosmetic Composition for Skin-aging Protection and Wrinkle Improvement Comprising the Extract of Nephelium lappaceum and Litchi chinensis sonn as Active Ingredient | |
US5674497A (en) | Hair growth promoter comprising extract of mulberry root bark and persimmon and/or paulownia, or extract of persimmon and paulownia | |
US10925915B2 (en) | Use of a Copaifera extract to combat alopecia and seborrhea | |
CA2139253C (en) | Skin external agent | |
KR100451885B1 (en) | Extracts of pomegranate for stoping the hair from falling out and composition of cosmetics containing the extracts of pomegranate | |
JPH03188019A (en) | Testosterone-5alpha-reductase inhibitor | |
JP4598900B2 (en) | Use of ginkgo flavonoid extracts substantially free of terpenes in the oral and dental field and compositions containing such extracts | |
KR20140145278A (en) | Cosmetic composition containing Cimicifuga heracleifolia extract, Cornus officinalis extract and Geranium nepalense extract for skin convergence and elasticity effect | |
JP2007509133A (en) | Cosmetic composition for improving wrinkles containing a red wrinkle extract {CosmeticsComposingsExtractingFractionMallotusjaponicusforImprovingSkinWrinkle} | |
KR20210083236A (en) | Composition for preventing hair loss and improving the scalp | |
JPS6293217A (en) | Hair tonic | |
KR20210071395A (en) | Cosmetic composition for promoting hair growth containing extracts of moringa oleifera and annona muricata as active ingredient | |
KR102076179B1 (en) | A cosmetic composition for alleviating skin irritation by vitamin c containing a mixed extract of iris lactea and doellingeria scabra | |
KR100681699B1 (en) | Hair cosmetic composition for treating dandruff, containing mung bean extract as an active ingredient | |
KR20030087236A (en) | Cosmetic Composition for Skin-Whitening Comprising Extract of Cnidium officinale | |
JP4587755B2 (en) | Anti-inflammatory agent, whitening agent, anti-aging agent, and skin cosmetic | |
JP6655296B2 (en) | Hair growth or hair growth promoter | |
JP3647296B2 (en) | Inhibition of tyrosinase activity and compositions containing the same | |
KR100744947B1 (en) | Cosmetic composition for skin whitening containing cheongung extract and protease as active ingredients | |
KR102815120B1 (en) | Compositions for cleansing and relieving hair loss, comprising Persicaria perfoliata extract as an active ingredient | |
KR100449345B1 (en) | Cosmetic Composition for Skin-Whitening Comprising Emblica officinalis Extract and Ramulus mori Extracts as Active Ingredients | |
KR100845721B1 (en) | Cosmetic composition for improving skin wrinkles containing white acid extract as an active ingredient | |
KR100984284B1 (en) | Hair tonic composition containing sewage, maca and mistletoe extract | |
KR20050026806A (en) | Cosmetic composition containing jujube extract | |
KR100773421B1 (en) | Hair loss prevention, hair growth promoting or hair growth composition, and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20020215 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20031226 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20040802 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20040924 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20040930 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20070903 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20080818 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20090812 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20100715 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20110713 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20120703 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20120703 Start annual number: 9 End annual number: 9 |
|
FPAY | Annual fee payment |
Payment date: 20130710 Year of fee payment: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20130710 Start annual number: 10 End annual number: 10 |
|
FPAY | Annual fee payment |
Payment date: 20140806 Year of fee payment: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20140806 Start annual number: 11 End annual number: 11 |
|
FPAY | Annual fee payment |
Payment date: 20150804 Year of fee payment: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20150804 Start annual number: 12 End annual number: 12 |
|
FPAY | Annual fee payment |
Payment date: 20170818 Year of fee payment: 14 |
|
PR1001 | Payment of annual fee |
Payment date: 20170818 Start annual number: 14 End annual number: 14 |
|
FPAY | Annual fee payment |
Payment date: 20180827 Year of fee payment: 15 |
|
PR1001 | Payment of annual fee |
Payment date: 20180827 Start annual number: 15 End annual number: 15 |
|
PR1001 | Payment of annual fee |
Payment date: 20200820 Start annual number: 17 End annual number: 17 |
|
PR1001 | Payment of annual fee |
Payment date: 20210825 Start annual number: 18 End annual number: 18 |
|
PC1801 | Expiration of term |
Termination date: 20220815 Termination category: Expiration of duration |